Literature DB >> 28372981

Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.

Jeffrey J Levine1, Robert A Somer2, Hitomi Hosoya3, Christian Squillante2.   

Abstract

Entities:  

Keywords:  Altered mental status; Immune check point inhibitor; Immunotherapy; PD-L1 inhibitor; Urothelial cell carcinoma

Mesh：

Substances：

Year:  2017        PMID： 28372981     DOI： 10.1016/j.clgc.2017.03.001

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  12 in total

Review 1.  Toxicity of tumor immune checkpoint inhibitors-more attention should be paid.

Authors:  Yu Liu; Hao Wang; Juan Deng; Chenglong Sun; Yayi He; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 2.  Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

Authors:  Iosune Baraibar; Ignacio Melero; Mariano Ponz-Sarvise; Eduardo Castanon
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

3.  Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.

Authors:  Yoshitaka Yamaguchi; Hikaru Nagasawa; Yuji Katagiri; Manabu Wada
Journal:  J Med Case Rep       Date:  2020-07-04

4.  Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.

Authors:  Andrés Laserna; Sudhakar Tummala; Neel Patel; Diaa Eldin Mohamed El Hamouda; Cristina Gutiérrez
Journal:  SAGE Open Med Case Rep       Date:  2018-08-02

5.  Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin.

Authors:  Ahwon Kim; Bhumsuk Keam; Hyeon Cheun; Soon Tae Lee; Hyung Seok Gook; Moon Ku Han
Journal:  J Clin Neurol       Date:  2019-03-11       Impact factor: 3.077

6.  Toxicities associated with checkpoint inhibitors-an overview.

Authors:  Laura Spiers; Nicholas Coupe; Miranda Payne
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

7.  Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.

Authors:  Rita Nader; Esther Tannoury; Tamina Rizk; Hady Ghanem
Journal:  Autops Case Rep       Date:  2021-04-15

Review 8.  Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review.

Authors:  Burcin Özdirik; Fabian Jost-Brinkmann; Lynn Jeanette Savic; Raphael Mohr; Frank Tacke; Christoph J Ploner; Christoph Roderburg; Tobias Müller
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

Review 9.  Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.

Authors:  Jennifer M Yoest
Journal:  Immunotargets Ther       Date:  2017-10-10

10.  De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma.

Authors:  Smathorn Thakolwiboon; Amputch Karukote; Henrik Wilms
Journal:  Cureus       Date:  2019-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.